In the present cooperative study between the AIEOP and the BFM national reference laboratories, we investigated the inter-laboratory concordance and prognostic value of MDD and MRD quantification by dPCR in a large cohort of NPM-ALK-positive ALCL patients, uniformly treated with ALCL99-type chemotherapy. This evidence concerns the gene ALK and anaplastic large cell lymphoma.